Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study-Reference-Cited by-同舟云学术

Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study

Published:2021-03-30 Issue:4 Volume:22 Page:567-579
ISSN:1175-0561
Container-title:American Journal of Clinical Dermatology
language:en
Short-container-title:Am J Clin Dermatol

Author:

Torres Tiago^ORCID,Puig Luis,Vender Ron,Lynde Charles,Piaserico Stefano,Carrascosa Jose M.,Gisondi Paolo,Daudén Esteban,Conrad Curdin,Mendes-Bastos Pedro,Ferreira Paulo,Leite Luiz,Lu Justin D.,Valerio J.,Bruni M.,Messina F.,Nidegger A.,Llamas-Velasco M.,del Alcazar E.,Mufti A.,White Kyra,Caldarola G.,Teixeira Laetitia,Romanelli Paolo,Desai K.,Gkalpakiotis Spyridon,Romanelli Marco,Yeung Jensen,Nogueira Miguel,Chiricozzi Andrea

Publisher

Springer Science and Business Media LLC

Subject

Dermatology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40257-021-00598-4.pdf

Reference31 articles.

1. Langley RGB, Krueger GG, Griffiths CEM. Psoriasis: Epidemiology, clinical features, and quality of life. Ann Rheum Dis. 2005;64:ii18–23 (discussion ii24–5).

2. Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20:1475.

3. Hu Y, Chen Z, Gong Y, Shi Y. A review of switching biologic agents in the treatment of moderate-to-severe plaque psoriasis. Clin Drug Investig. 2018;38:191–9.

4. Costanzo A, Malara G, Pelucchi C, Fatiga F, Barbera G, Franchi A, et al. Effectiveness end points in real-world studies on biological therapies in psoriasis: systematic review with focus on drug survival. Dermatology. 2018;234:1–12.

5. van den Reek JMPA, Kievit W, de Jong EMGJ. Comment on “Drug survival analysis is not a good method for assessing the safety or effectiveness of systemic therapies in psoriasis.” Actas Dermosifiliogr. 2017;108:695–6.

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Review of the Factors Affecting the Redefinition of Therapeutic Use in Metropolitan Cities during the Emerging and Re-emerging Pandemics;Romanian Journal of Military Medicine;2024-09-01

2. Investigating EGFR, BRAF, and RAS Mutations in Oral and Cutaneous Squamous Cell Neoplasms: A Preliminary Report on Romanian Patients;Romanian Journal of Military Medicine;2024-09-01

3. Real-World Data on Brodalumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: An Observational Study from the Czech Republic BIOREP Registry;Advances in Therapy;2024-08-29

4. Persistence of advanced systemic pharmacological treatment of moderate‐to‐severe psoriasis among bio‐naïve patients—A retrospective register‐based cohort study in Finland and Sweden;Journal of the European Academy of Dermatology and Venereology;2024-08-02

5. Drug survival for biologics in psoriasis patients: real world evidence for Greece during the period 2016-2020;Clinical and Experimental Dermatology;2024-07-06